Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 32,649 | 22,218 | 398,655 | 30,773 | 22,035 |
| Cost of Goods | 12,951 | 15,717 | 23,058 | 14,105 | 9,819 |
| Gross Profit | 19,698 | 6,501 | 375,597 | 16,668 | 12,216 |
| Operating Expenses | 83,182 | 78,745 | 62,059 | 74,121 | 65,261 |
| Operating Income | -62,533 | -71,527 | 313,596 | -57,348 | -52,226 |
| Interest Expense | 6,860 | 6,130 | 6,500 | 6,709 | 6,366 |
| Other Income | 1,214 | 893 | 330 | 5,652 | 953 |
| Pre-tax Income | -68,179 | -76,764 | 307,426 | -58,405 | -57,639 |
| Income Tax | N/A | -41 | 13,403 | N/A | N/A |
| Net Income Continuous | -68,179 | -76,723 | 294,023 | -58,405 | -57,639 |
| Net Income | $-68,179 | $-76,723 | $294,023 | $-58,405 | $-57,639 |
| EPS Basic Total Ops | -1.58 | -1.79 | 6.94 | -1.37 | -1.36 |
| EPS Basic Continuous Ops | -1.58 | -1.79 | 6.94 | -1.37 | -1.36 |
| EPS Diluted Total Ops | -1.58 | -1.79 | 6.84 | -1.37 | -1.36 |
| EPS Diluted Continuous Ops | -1.58 | -1.79 | 6.84 | -1.37 | -1.36 |
| EBITDA(a) | $-58,672 | $-67,476 | $317,667 | $-53,014 | $-48,442 |